Effect of ethnicity on live birth rates after in vitro fertilisation/intracytoplasmic sperm injection treatment: analysis of UK national database by Maalouf, Walid E. et al.
Maalouf, Walid E. and Maalouf, Wadih and Campbell, 
Bruce and Jayaprakasan, K. (2016) Effect of ethnicity on 
live birth rates after in vitro fertilisation/intracytoplasmic 
sperm injection treatment: analysis of UK national 
database. BJOG: An International Journal of Obstetrics 
and Gynaecology . ISSN 1471-0528 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/40379/1/Maalouf_et_al-2016-
BJOG__An_International_Journal_of_Obstetrics__Gynaecology%20submitted.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the University of Nottingham End User licence and may 
be reused according to the conditions of the licence.  For more details see: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
 
 
1 
 
Effect of Ethnicity on Live Birth Rates after IVF/ICSI Treatment: Analysis of a National Database 1 
 2 
AUTHORS:  3 
Dr Walid Maalouf, PhD1  4 
Dr Wadih Maalouf, PhD2 5 
Professor Bruce Campbell, PhD, DSc1  6 
Dr Kannamannadiar Jayaprakasan, MD, PhD1,3 7 
1Division of Obstetrics and Gynaecology, Faculty of Medicine & Health Sciences University of Nottingham, 8 
Nottingham, Nottinghamshire, United Kingdom NG7 2UH  9 
2Prevention, Treatment and Rehabilitation Section. United Nations Office, Vienna, Austria 10 
3Derby Fertility Unit, Royal Derby Hospital, Derby, United Kingdom DE22 3NE 11 
Correspondence to: 12 
Dr Kannamannadiar Jayaprakasan  13 
Tel: 01332 787161 14 
Fax: 01332 202761 15 
Email: kanna.jayaprakasan@nhs.net;  k.jayaprakasan@nottingham.ac.uk  16 
Running Title: 17 
Ethnicity and Success of ART 18 
19 
 
 
2 
 
ABSTRACT 20 
Objective: 21 
To evaluate the effect of ethnicity of women on the outcome of In-Vitro Fertilisation (IVF) or Intra-22 
Cytoplasmic Sperm Injection (ICSI) treatment. 23 
Design: 24 
Observational cohort study 25 
Setting: 26 
UK National Database  27 
Population: 28 
Data from 2000 to 2010 involving 38,709 women undergoing their first IVF/ICSI cycle were analysed. 29 
Methods:  30 
Anonymous data were obtained from the Human Fertilization and Embryology Authority (HFEA), the 31 
statutory regulator of IVF and ICSI treatment in the UK. Data analysis was performed by regression analysis 32 
with adjustment for age, cause and type of infertility and treatment type (IVF or ICSI) to express results as 33 
odds ratio and 95% confidence intervals.  34 
Main outcome measures:  35 
Live birth rate per cycle of IVF or ICSI treatment 36 
Results: 37 
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While white Irish (OR: 0.73; 95% CI: 0.60 - 0.90), Indian (0.85; 0.75 - 0.97), Bangladeshi (0.53: 0.33 – 0.85), 38 
Pakistani (0.68; 0.58 - 0.80), Black African (0.60; 0.51 – 0.72), and other non-Caucasian Asian (0.86; 0.73 – 39 
0.99) had a significantly lower odds of live birth rates per fresh IVF/ICSI cycle than White British women, 40 
ethnic groups of White European (1.04; 0.96 – 1.13), Chinese (1.12; 0.77 – 1.64), Black Caribbean (0.76; 41 
0.51 – 1.13), Middle Eastern (0.73; 0.51 – 1.04), Mediterranean European (1.18; 0.83 – 1.70) and Mixed 42 
race population (0.94; 0.73 – 1.19) had live birth rates that did not differ significantly. The cumulative live 43 
birth rates also showed similar pattern across different ethnic groups.   44 
Conclusion: 45 
Ethnicity is a major determinant of IVF/ICSI treatment outcome as indicated by significantly lower live 46 
birth rates in some of the ethnic minority groups compared to white British women.  47 
Keyword(s): Ethnicity, infertility, assisted conception, IVF, ICSI, Live birth, Embryo. 48 
 49 
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INTRODUCTION 50 
Infertility is a major public health problem that affects 10-15 % of the population and an exponentially 51 
growing number of people are seeking infertility treatment. Over the last decade, the advancement and 52 
acceptance of infertility treatment has been significant. Despite rapid advancement in infertility 53 
treatment, ethnicity as a primary prognostic factor has attracted limited attention unlike other areas in 54 
medicine due to paucity of robust evidence. Today, in the United Kingdom, for example, the treatment 55 
protocols for IVF/ ICSI treatment chosen for patients are based on factors such as age, BMI and ultrasound 56 
and endocrine markers of ovarian reserve (1), but not on the ethnic background of the patient. Further, 57 
most treatment protocols devised are based on research studies conducted in Caucasian population of 58 
Europe and North America with extrapolating the resulting data and applying the practices to population 59 
worldwide representing various ethnicities and races.   60 
 61 
There are a few published studies highlighting ethnicity as a determining factor of importance in IVF/ICSI 62 
treatment outcome (2-9).  However, most studies are based on small sample size and subjects described 63 
are of selected ethnicities and races and not representative of a general population sample, while larger 64 
published studies are based on the population of the USA. Another major issue of most published data is 65 
the pooling of different ethnicities under single wider categories such as Asians, which can include women 66 
from China, Japan, Korea, India, Bangladesh or Pakistan, who are significantly different racially and 67 
ethnically between each other. Further, most studies, especially that of smaller sample sizes, were from 68 
a single fertility unit (2), and a number of ethnic groups were under-represented to generate a valid 69 
conclusion. 70 
 71 
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We, therefore, accessed a large anonymized patient register held by the Human and Fertilisation and 72 
Embryology Authority (HFEA) of the UK with an overall objective to evaluate the effect of ethnicity of 73 
women on the clinical outcome of In-Vitro Fertilisation (IVF) or Intra-Cytoplasmic Sperm Injection (ICSI) 74 
treatment in a large population. The HFEA regulates fertility clinics in the UK, and as part of its role, it 75 
requires that all clinics submit the baseline data for each treatment cycle, which also include the ethnicity 76 
of women. 77 
 78 
MATERIALS AND METHODS 79 
This cohort study is carried out in the UK by reviewing the anonymised data obtained from the Human 80 
Fertilisation and Embryology Authority (HFEA) registry covering the period 2000-2010. Only women 81 
undergoing their first cycle of IVF/ICSI treatment were included and this was done to ensure that the data 82 
were truly unbiased (Figure 1). Approval for the study was granted by the National Health Service 83 
Research Ethics Committee and the Nottingham University NHS Trust Research and Development 84 
Department. The process of extracting data was in keeping with the rules governing data protection. 85 
The variables extracted include women’s age, ethnicity, cause and type of infertility, duration of infertility, 86 
IVF or ICSI, number of embryos transferred, and day of embryo transfer. Outcomes included number of 87 
oocytes retrieved, number of oocytes fertilised by IVF or ICSI, number of embryos created, fertilisation 88 
rate (number of oocytes fertilised per number of oocytes inseminated), clinical pregnancy rate (number 89 
of pregnancies with positive heart beat on ultrasound per number of women started IVF treatment), 90 
implantation rate (number of clinical pregnancies per number of embryos transferred), while live birth 91 
rate (proportion of cycles started that resulted in a live birth) was the main outcome measure in this study. 92 
Ethnicity was self-reported then categorised using nationally agreed guidelines 93 
 94 
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Data analysis was carried out using STATA 8.1. Univariate analysis using the available variables was done 95 
first to assess the differences in baseline characteristics between White British women and those from 96 
other ethnic groups. Based on the distribution, bivariate analysis of continuous data was done with the 97 
Student’s t-test or Mann-Whitney U-test. The relationship between two categorical variables was 98 
analysed by performing unadjusted odds ratio (OR) with confidence interval (CI), Chi-square and Fisher 99 
exact tests. When the confidence interval around the odds ratio did not include 1.00, the difference was 100 
considered to be statistically significant in all statistical tests. Logistic regression models were used to 101 
assess the effects of ethnicity on the study outcomes controlling for confounding variables. The White 102 
British ethnic group was taken as reference group in the model given that it is the largest ethnic group in 103 
the data set. To estimate the independent contribution of ethnic minority group to treatment outcomes 104 
(relative to the White British reference group), multivariate logistic regression analyses were performed. 105 
Potential confounding factors found to be statistically significant in univariate analyses and variables 106 
regarded as clinically significant were included in the models. For continuous data, a multivariate linear 107 
regression model was used controlling for the same confounders in the logistic models. 108 
RESULTS 109 
Demographic information and prevalence of causes of infertility in patients of different ethnic background 110 
Patients undergoing their first cycle of treatment were analysed in this study (Figure 1). A cohort of 38,709 111 
distributed as White British – 28,408 (73.39%), White Irish – 635 (1.64%), White European – 3201 (8.27%), 112 
South-Asian Indian – 1226 (3.17%), South-Asian Bangladeshi – 105 (0.27%), South-Asian Pakistani – 878 113 
(2.27%), Chinese – 135 (0.35%), Black British – 168 (0.43%), Black African – 879 (2.27%), Black Caribbean 114 
-1495 (3.86%), Mediterranean European – 144 (0.37%), Middle-Eastern – 171 (0.44%), Mixed Race – 366 115 
(0.95%) and Other Asian – 898 (2.32%).  116 
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The mean age of patients ranged from 29.7 years to 35.8 years (Table 1). Patients of South-Asian Indian, 117 
South-Asian Pakistani, Black Caribbean and Middle-Eastern background were significantly younger than 118 
the White British women, while White Irish, White European and Black British women were significantly 119 
older than the reference ethnic group (p<0.05). The causes of infertility vary between ethnic groups as 120 
shown in Table 1 and figure 2. 121 
 122 
Effects of ethnicity of patients on ovarian response and Clinical pregnancy rates  123 
After adjusting for the all variables including age patient at time of treatment, cause of female or male 124 
infertility, and type of treatment (ICSI vs IVF) South Asian Bangladeshi, South Asian Pakistani, Black African, 125 
Middle Eastern, and Other Asians have a significantly lower number of eggs collected than White British 126 
patients (Table 2). Patients of a mixed race also demonstrated a significantly lower number of eggs 127 
collected per treatment cycle. On the other hand, White Europeans had significantly higher number of 128 
eggs collected (P<0.0001).  There was no significant differences in the method of fertilisation (IVF or ICSI) 129 
used between patients of different ethnicities. The data on number of embryos transferred, 130 
cryopreserved and the day of embryo transfer have been shown in table 2. South Asian Indian, South 131 
Asian Bangladeshi, South Asian Pakistani, Black British, Black African, Black Caribbean and Middle Eastern 132 
were at higher risk of not reaching embryo transfer stage (cycle cancellation prior to embryo transfer after 133 
treatment started) (Table 2). The reported OHSS rates have been generally similar across all the ethnic 134 
groups except higher incidence reported at egg collection in Black British and Black Caribbean. 135 
 136 
White Irish, South Asian Indian, South Asian Bangladeshi, South Asian Pakistani, Black African, and Other 137 
Asian groups had a significantly lower odds of clinical pregnancy than White British patients after adjusting 138 
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for age, cause of subfertility and type of treatment (Table 3). On the other hand, White Europeans had a 139 
significantly higher odds (OR: 1.09 (1.01-1.18) after adjusting for the aforementioned characteristics. 140 
Other Ethnicities had comparable outcome to that of White British patients.  141 
 142 
Effects of ethnicity of patients on the primary outcome, live birth rate 143 
After adjusting for the all variables including age patient at time of treatment, cause of female or male 144 
infertility, and type of treatment (ICSI vs IVF), White Irish, South Asian Indian, South Asian Bangladeshi, 145 
South Asian Pakistani, Black African, and Other Asian had a significantly lower odds of live birth than White 146 
British patients (Table 3 and Figure 3). Also, it is worth noting that, Middle Eastern had an odds ratio 147 
indicating a tendency (borderline significance p: 0.08) of lower odds of live birth outcomes (OR: 0.73 (0.51 148 
– 1.04)). Other Ethnicities had comparable outcome to that of White British patients.  149 
 150 
DISCUSSION 151 
The data from this large UK national database (HFEA) has shown that ethnicity is a major independent 152 
factor determining the chances of IVF or ICSI treatment success. Live birth rates following IVF or ICSI 153 
treatment were significantly lower in some of the ethnic groups (White Irish, South Asian Indian, South 154 
Asian Bangladeshi, South Asian Pakistani, Black African, and Other Asian) compared with white British 155 
women, which suggests that ethnicity is a major determinant of live birth following IVF or ICSI treatment. 156 
While the reason for this association is difficult to explain, the potential factors could be the observed 157 
differences in cause of infertility, ovarian response, fertilisation rates and implantation rates, which are 158 
all independent predictors of IVF success. 159 
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While there are a number of similar studies reported (2-5, 7, 9-18), this study is unique in the sub-160 
categorising of ethnicities to represent a more homogeneous subgroups of racial, cultural and lifestyle 161 
similarities: for example, Asian ethnicity clearly has very distinct ethnic subgroups such as Chinese, Indian, 162 
Pakistani and Bangladeshi among others. More over, this is the largest study to date to evaluate the effect 163 
of individual sub-ethnic groups as an independent factor on the success rates of IVF/ICSI treatment with 164 
the data derived from a reasonably large number of women from various individual ethnic groups treated 165 
in all the UK fertility units. As noted in most studies, varied underlying causes of infertility and age at which 166 
women undergoing IVF were evident in ethnic groups, however, the data suggests that after controlling 167 
for age and cause of subfertility, ethnicity of women remained a significant factor influencing the outcome 168 
of the treatment.  169 
 170 
The quantitative ovarian reserve does not seem to be varying significantly across various ethnic groups, 171 
however, the observed differences of treatment outcome in the ethnic minority groups may be reflective 172 
of varied qualitative ovarian reserve or sperm factor as indicated by reduced fertilization rates in South 173 
Asian Indian, South Asian Bangladeshi, South Asian Pakistani, Black British, Black African, Black Caribbean, 174 
Middle Eastern and Other Asian population. While genetic background could be a potential determinant 175 
of egg and sperm quality, variation in environmental exposures relating to different life style, dietary 176 
factors, socio-economic and cultural factors could be influencing issues including the egg and sperm 177 
quality, accessibility of fertility treatment services and behaviour towards seeking medical care for fertility 178 
and consequently the reproductive outcomes. The observed implantation rates have also been varied 179 
among different ethnic groups with reduced implantation noted in white Irish and Black African 180 
population. The possible increased prevalence of PCOS in south Asian population may have adverse 181 
influence on oocyte quality and endometrial function resulting in low implantation rates. While increased 182 
prevalence of uterine and tubal factor infertility in Black African population could explain the reason for 183 
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reduced endometrial receptivity and implantation, the reason for low implantation rate in Irish population 184 
is unclear.  185 
 186 
The observed variation in IVF treatment success among different ethnic groups raises a number of 187 
challenges for current clinical practices in terms of counselling patients about their realistic probabilities 188 
of successful outcome, individually tailored treatment protocols, and policies regarding referral and 189 
treatment criteria for patients of different ethnic background. Research is needed to understand the 190 
reasons behind the variation in treatment outcome between ethnic groups and the studies evaluating 191 
treatment strategies on modifying IVF outcome should incorporate ethnicity as a major determinant 192 
factor. Modifications in clinical strategies to bring about equivalent success rates among all ethnic groups 193 
can be achieved after the relationship between ethnicity and IVF outcome is better understood.  194 
 195 
One of the key strengths of this population study is the sample size, it is the largest cohort study with UK 196 
wide representation for all ethnic and sub-ethnic minorities. As the sample size is significantly large, it was 197 
possible to statistically analyse the success rates of the IVF cycles among each of the sub-ethnic groups 198 
without merging the categories which was one of the drawbacks of the largest US based population 199 
studies that were previously published (5). However, the numbers in some of the sub-ethnic minorities 200 
(eg: Bangladeshi population) were low in our study. The use of the UK HFEA National database as a basis 201 
for this analysis is a major strength of the paper as its robust auditing and stringent regulations that 202 
standardizes treatment across all clinics with regards to variables such as the number of embryos 203 
transferred back to the patient and number of previous treatment cycles means that the data is reliable 204 
and consistent. Further, only first cycles are included which again gives a genuinely true comparison of 205 
IVF outcome between various ethnic groups as opposed to inclusion of multiple cycles from each women, 206 
which would have added bias to the results. The quality of the data included in the study may be limited 207 
 
 
11 
 
because of missing the ethnicity data in a significant proportion of cases reported to the HFEA (Figure 1). 208 
Factors like BMI, smoking and alcohol consumption were not collected by the HFEA and therefore could 209 
not be accounted for in this study. Further, a significant proportion of HFEA reported cycle do not have 210 
Socio-economic factors are also not accounted for, however, private and government funded patients are 211 
evenly represented in the register, and also, the number of patients analysed in the different ethnic sub-212 
groups is large and represent the UK national distribution respectively.  213 
 214 
CONCLUSION 215 
Live birth rates following IVF treatment were significantly lower in some of the ethnic groups compared 216 
with white British women, which suggests that ethnicity is a major determinant of live birth following IVF 217 
or ICSI treatment. While the prevalence of various causes of infertility vary in different ethnic groups, the 218 
ethnicity of the patient is independently correlated with success rates of IVF treatment cycle after 219 
controlling for age and causes of infertility. Even though data on other variables such diet and socio-220 
economic factors are not reported and they can potentially alter the outcome of clinical treatment, such 221 
variables are non-modifiable and therefore ethnicity should be considered while counselling women and 222 
couples about their realistic chances of IVF success. This study is just a first step and further research is 223 
needed to understand the reasons behind the variation in treatment outcome between ethnic groups and 224 
move towards tailoring tangible protocols specifically suited to each ethnic group to maximize their IVF/ 225 
ICSI success without compromising their safety.   226 
 227 
228 
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Table 1. Baseline Characteristics of the patients according to their Ethnic Group, and Unadjusted Effect of those Characteristics on Live Birth Outcome during the first treatment 
cycle, Expressed as OR +/- 95% CI  
 White 
British 
White 
Irish 
White 
European 
South 
Asian 
Indian 
South Asian 
Bangladeshi 
South 
Asian 
Pakistani 
Chinese Black 
British  
Black 
African 
Black 
Caribbean  
Mediterra
nean 
European 
Middle 
Eastern 
Mixed 
Race 
Other 
Asian 
Sample Size, N % 28408  
(76.1) 
635 
1.7) 
3201 
(8.6) 
1226 
(3.3) 
105 
(0.3) 
878 
(2.4) 
135 
(0.4) 
168 
(0.5) 
879 
(2.4) 
1495 
(0.4) 
144 
(0.4) 
171 
(0.5) 
366 
(1.0) 
898 
(2.4) 
Mean Age  
SD 
34.4  
4.6 
35.8  
4.1** 
34.9 
 4.3** 
32.8 
 4.3** 
29.7 
 4.3 
31.2 
 4.9* 
34.9 
 4.4 
35.3 
 5.6** 
34.5 
 4.7 
34.1 
 5.4** 
33.2 
 5.0 
32.4 
 5.8** 
34.6 
 4.8 
33.6 
 4.6 
Cause of 
Infertility –  
              
Tubal (%) 4687 
(16.5) 
80 
(12.6)** 
439 
(13.7)** 
165 
(13.5)* 
16 
(15.2) 
130 
(14.8) 
33 
(24.4)^ 
45 
(26.8)^^ 
267 
(30.4)^^ 
69 
(46.3)^^ 
13 
(9.0)* 
27 
(15.8) 
76 
(20.8)* 
145 
16.1 
Uterine, % 234 
(0.8) 
5 
(0.8) 
41 
(1.8)^^ 
19 
(1.6)^^ 
1 
(0.9) 
7 
(0.8) 
2 
(1.5) 
14 
(3.3)^^ 
73 
(8.3)^^ 
7 
(8.7)^^ 
3 
(2.1) 
4 
(2.3)^^ 
3 
(0.8) 
12 
(1.3) 
Ovulatory, % 3359 
(11.8) 
59 
(9.3) 
315 
(9.8)** 
216 
(17.6)^^ 
29 
(17.6)^^ 
154 
(17.5)^^ 
19 
(14.1) 
14 
(8.9) 
79 
(9.0)* 
14 
(9.4) 
17 
(11.8) 
26 
(15.2) 
41 
(11.2) 
154 
(17.2)^^ 
Endometriosis, %  2302 
(8.1) 
46 
(7.3) 
252 
(7.9) 
94 
(7.7) 
4 
(3.8) 
57 
(6.5) 
9 
(6.7) 
9 
(5.4) 
36 
(4.1) 
8 
(5.4) 
10 
(6.9) 
5 
(2.9) 
42 
(11.5)^ 
70 
(7.8) 
Unexplained, % 8605 
(30.3) 
188 
(29.6) 
1004 
(31.4) 
367 
(29.9) 
24 
(22.9) 
221 
(25.2)** 
44 
(32.6) 
34 
(20.2)** 
167 
(19.0)** 
16 
(10.7)** 
49 
(34.1) 
44 
(25.7) 
97 
(26.5) 
274 
(30.5) 
Male Factor, % 11453 
(40.32) 
266 
(41.9) 
1314 
(41.1) 
456 
(37.2)* 
36 
(34.3) 
380 
(43.3)^ 
39 
(28.9)** 
65 
(38.7) 
365 
(41.5) 
57 
(38.3) 
58 
(40.3) 
69 
(40.4) 
136 
(37.2) 
309 
(34.4)** 
*Significantly lower (*P<0.05, ** P<0.01);   ^ Significantly higher (^P<0.05, ^^ P<0.01) 282 
 283 
284 
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Table 2. Treatment and Outcome Characteristics of the patients according to their Ethnic Group 
 White 
British 
White 
Irish 
White 
European 
South 
Asian 
Indian 
South Asian 
Bangladeshi 
South 
Asian 
Pakistani 
Chinese Black 
British  
Black 
African 
Black 
Caribbean  
Mediterra
nean 
European 
Middle 
Eastern 
Mixed 
Race 
Other 
Asian 
Sample Size, N % 28408  
(76.1) 
635 
1.7) 
3201 
(8.6) 
1226 
(3.3) 
105 
(0.3) 
878 
(2.4) 
135 
(0.4) 
168 
(0.5) 
879 
(2.4) 
1495 
(0.4) 
144 
(0.4) 
171 
(0.5) 
366 
(1.0) 
898 
(2.4) 
IVF Cycles, N % 
(the rest were 
ICSI) 
15,450 
(54.6) 
334 
(52.8) 
1644 
(51.7)* 
656 
(53.8) 
67 
(64.4)^^ 
458 
(52.5) 
85 
(62.9) 
102 
(60.7) 
434 
(49.5)* 
75 
(50.3) 
77 
(53.8) 
80 
(46.8)* 
198 
(54.4) 
500 
(56.0) 
Mean No. Eggs 
collected  SD 
9.5 
 6.5 
8.6 
 6.2** 
10.1 
 6.8^^ 
9.9 
 6.9^ 
8.7 
 7.1 
9.9 
 6.8 
8.7 
 5.9 
8.9 
 7.3 
8.9 
 7.4* 
10.4 
 7.9 
9.5 
 6.3 
8.9 
 6.7 
8.9 
 6.2 
9.1 
 6.3 
Fertilisation rate 
Mean +/- SD 
0.59  
0.26 
0.59  
0.26 
0.59   
0.25 
0.55   
0.25 ** 
0.53   
0.27* 
0.53  
0.27 ** 
0.60  
0.28 
0.47  
0.29** 
0.51  
0.27** 
0.52   
0.27 * 
0.54  
0.25  
0.52  
0.29** 
0.57  
0.26  
0.55  
0.26 ** 
Mean No. 
Embryos created 
 SD 
5.5 
 4.4 
5.0* 
 4.1 
5.9 
 4.6^^ 
5.5 
 4.5 
4.7 
 4.5 
5.1 
 4.3* 
4.1 
 3.8 
4.2 
 4.1** 
4.6 
 4.6** 
5.4 
 4.9 
5.3 
 4.3 
4.4 
 4.0** 
4.9 
 4.0** 
4.9 
 4.1** 
Mean No. Embryo 
Stored  SD 
1.39 
3.02 
1.07 
 2.66* 
1.36 2.86 1.48  3.00 1.25  2.97 1.30  
3.04 
0.75  
1.86** 
0.67  
2.19** 
0.91 
2.31** 
1.26  3.04 
** 
0.78  
1.54 
0.88  
2.43** 
1.17  
2.50** 
0.99  
2.27** 
No. of Embryos Transferred 
0,  N 
 % 
4,262 
(15.0) 
95 
(15.0) 
449 
(14.0) 
216 
(17.6)* 
24 
(22.9)* 
175 
(19.9)* 
22 
(16.3) 
49 
(29.2)* 
220 
(25.0)* 
35 
(23.5)* 
28 
(19.4) 
40 
(23.4)* 
51 
(13.9) 
157 
(17.5) 
1,  N 
 % 
7,309 
(25.7) 
163 
(25.7) 
892 
(27.9) 
389 
(31.7) 
33 
(31.4) 
197 
(22.4) 
33 
(24.4) 
32 
(19.0) 
192 
(21.8) 
39 
(22.8) 
30 
(20.8) 
39 
(22.8) 
93 
(25.4) 
203 
(22.6) 
2,  N 
 % 
16,263 
(57.3) 
350 
(55.1) 
1,758 
(54.9) 
610 
(49.8) 
48 
(45.7) 
502 
(57.2) 
77 
(57.1) 
75 
(44.6) 
447 
(50.9) 
73 
(48.9) 
82 
(56.9) 
88 
(51.5) 
214 
(58.5) 
524 
(58.4) 
3,  N 
 % 
574 
(2.0) 
27 
(4.3) 
102 
(3.2) 
11 
(0.9) 
0 
(0.0) 
4 
(0.5) 
3 
(2.2) 
12 
(7.1) 
20 
(2.3) 
2 
(1.3) 
4 
(2.8) 
4 
(2.3) 
8 
(2.2) 
14 
(1.6) 
OHSS reported               
At  Egg collection, 
N % 
173 
(0.6) 
3 
(0.5) 
20 
(0.6) 
11 
(0.9) 
2 
(1.9) 
7 
(0.8) 
0 
(0.0) 
6 
(3.6)^^ 
6 
(0.7) 
3 
(2.0)^ 
2 
(1.4) 
2 
(1.2) 
0 
(0.0) 
9 
(1.0) 
At Embryo 
Transfer, N % 
632 
(2.2) 
17 
(2.7) 
67 
(2.1) 
30 
(2.5) 
4 
(3.8) 
24 
(2.7) 
2 
(1.5) 
3 
(1.8) 
15 
(1.7) 
4 
(2.7) 
3 
(2.1) 
4 
(2.3) 
6 
(1.6) 
14 
(1.6) 
Implantation rate  
N % 
22,056 
(24.6) 
507 
(17.6)* 
2,539 
(25.0) 
932 
(25.2) 
75 
(20.8) 
648 
(23.6) 
104 
(27.9) 
109 
(24.8) 
615 
(17.7)* 
108 
(24.1) 
102 
(30.6) 
121 
(24.8) 
291 
(22.7) 
675 
(23.0) 
Clinical Pregnancy 
N % 
9830 
(34.6) 
177 
(27.9)** 
1142 
(35.6) 
396 
(32.3) 
33 
(31.4) 
264 
(30.1)* 
47 
(34.8) 
44 
(26.2)* 
196 
(22.3)* 
43 
(28.9) 
57 
(39.6) 
57 
(33.3) 
114 
(31.1) 
290 
(32.3) 
Live Birth (LB)  
N%  
7507 
(26.4) 
122 
(17.2)* 
848 
(26.5) 
313 
(25.5) 
22 
(20.1) 
208 
(23.7) 
38 
(28.1) 
37 
(22.0) 
153 
(17.4)* 
32 
(21.5) 
45 
(31.2) 
40 
(23.4) 
90 
(24.6) 
221 
(24.6) 
*Significantly lower (*P<0.05, ** P<0.01);   ^ Significantly higher (^P<0.05, ^^ P<0.01) 
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Table 3. Multivariate analysis for number of eggs collected (coefficient and 95% CI), clinical pregnancy rate and live birth rate  (Odds Ratio and 95% CI ). Adjusted for age, cause 
of infertility and treatment type (IVF or ICSI) 
  White 
British 
White 
Irish 
White 
European 
South 
Asian 
Indian 
South Asian 
Bangladeshi 
South 
Asian 
Pakistani 
Chinese Black 
British  
Black 
African 
Black 
Caribbean  
Mediterra
nean 
European 
Middle 
Eastern 
Mixed 
Race 
Other 
Asian 
Sample Size, N % 28408  
(76.1) 
635 
1.7) 
3201 
(8.6) 
1226 
(3.3) 
105 
(0.3) 
878 
(2.4) 
135 
(0.4) 
168 
(0.5) 
879 
(2.4) 
1495 
(0.4) 
144 
(0.4) 
171 
(0.5) 
366 
(1.0) 
898 
(2.4) 
Number of eggs 
collected 
1 - 0.25   
(-0.75 to 
0.25) 
0.90 
(0.67 to 
1.12)^ 
-0.18     
(-0.54 to 
0.18) 
-2.63      
(-3.85 to -
1.41)* 
-0.81      
(-1.23 to 
-0.38)* 
-0.67    
(-1.73 to 
0.40) 
-0.11      
(-1.07 to 
0.85) 
-0.43      
(-0.87 to 
-0.01)* 
0.83    
(-0.19 to 
1.85) 
-0.36   
(-1.39 to 
0.68) 
-1.35    
(-2.30 
to -
0.39)* 
-0.51 
(-1.16 
to 
0.14) 
-0.79      
(-1.21 to 
-0.38)* 
Clinical pregnancy 
rate 
1 0.81 
(0.68 – 
0.97)* 
1.09 (1.01 
– 1.18)^ 
0.80 (0.71 
– 0.91)* 
0.61 (0.40 – 
0.92)* 
0.63 
(0.54 – 
0.73)* 
1.04 
(0.73 – 
1.49) 
0.74 
(0.52 – 
1.06) 
0.56 
(0.47 – 
0.66)* 
0.77 (0.54 
– 1.11) 
1.16 
(0.82 – 
1.64) 
0.81 
(0.59 – 
1.13) 
0.88 
(0.70 – 
1.10) 
0.84 
(0.73 – 
0.97)* 
Live birth rate 1 0.73 
(0.60 - 
0.90)* 
1.04 (0.96 
– 1.13) 
0.85 (0.75 
- 0.97)* 
0.53 (0.33 – 
0.85)* 
0.68 
(0.58 - 
0.80)* 
1.12 
(0.77 – 
1.64) 
0.86 
(0.60 – 
1.26) 
0.60 
(0.51 – 
0.72)* 
0.76 (0.51 
– 1.13) 
1.18 
(0.83 – 
1.70) 
(OR: 
0.73 
(0.51 – 
1.04) 
0.94 
(0.73 – 
1.19) 
0.86 
(0.73 – 
0.99)* 
 286 
*Significantly lower (*P<0.05);   ^ Significantly higher (^P<0.05) 287 
  288 
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Figure 1. Flowchart demonstrating data filtering for inclusion and exclusion from the study. 289 
 290 
 291 
 292 
 293 
294 
Total treatment cycles during the study 
period (n= 115,950) 
Treatment cycles with ethnicity data 
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 (n= 66,597) 
Treatment cycles with ethnicity data 
recorded and primary outcome recorded  
(n= 60,955) 
First fresh non-donor  
IVF/ ICSI treatment cycles  
 (n= 38,709) 
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Figure 2: Causes of infertility among various ethnic groups; reference group (White British) in green, significantly 295 
higher or lower odds in purple or orange respectively, and no statistical difference to the reference group in black. 296 
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Figure 3: Live birth rate among various ethnic groups; reference group (White British) in green, significantly lower 325 
odds in purple or orange respectively, and no statistical difference to the reference group in black. 326 
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